Compare National Beverage Corp. (FIZZ) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
National Beverage Corp. vs GE HealthCare Technologies Inc. Common Stock — how do they compare? National Beverage Corp. trades at $34.68 (market cap $3.14B), while GE HealthCare Technologies Inc. Common Stock trades at $69.82 (market cap $30.93B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 9.9× National Beverage Corp.'s market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while National Beverage Corp. pays none. Which is the better fit depends on your goals.
| FIZZ | GEHC | |
|---|---|---|
Market Cap | $3.14B | $30.93B |
Volume | 359,096 | 5,033,451 |
Sector | Consumer Staples | Health |
52-Week High | $37.73 | $88.16 |
52-Week Low | $29.20 | $59.48 |
Typical Hold Time | 32 Days | — |
Enterprise Value | $3.09B | $39.39B |
Dividend Yield | — | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FIZZ trades at $34.68, up 5.12% today, with a bullish technical signal from moving averages despite recent earnings misses. The stock shows strong profitability with 36.21% gross margin and 40.13% ROE, but faces margin pressure from input costs. Recent Q1 2027 revenue of $330.7M marked the first year-over-year growth since Q1 2026, though EPS declined to $0.50.
Outlook remains cautious with 50% analyst sell ratings reflecting stalled growth and margin challenges. The special dividend reduced equity, while tariff impacts pressure profits. Technical strength contrasts with fundamental headwinds, creating a mixed investment case with execution risk as the key variable.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About National Beverage Corp.
National Beverage Corp is one of the top 10 non-alcoholic beverage companies in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls most of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for big-box retailers, direct-store-delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants). It is controlled by chairman and CEO Nick Caporella, who owns over 73% of the common stock.
Read more on FIZZ →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
